1. Home
  2. ALLO vs TLRY Comparison

ALLO vs TLRY Comparison

Compare ALLO & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$0.76

Market Cap

452.6M

Sector

Health Care

ML Signal

HOLD

Logo Tilray Brands Inc.

TLRY

Tilray Brands Inc.

SELL

Current Price

$2.35

Market Cap

533.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ALLO
TLRY
Founded
2017
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
452.6M
533.5M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
ALLO
TLRY
Price
$0.76
$2.35
Analyst Decision
Strong Buy
Buy
Analyst Count
12
10
Target Price
★ $9.00
$5.72
AVG Volume (30 Days)
★ 11.2M
4.3M
Earning Date
11-05-2026
10-08-2026
Dividend Yield
N/A
N/A
EPS Growth
34.09
★ 55.69
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.44
Revenue Next Year
$72.02
$5.29
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.74
$0.77
52 Week High
$4.46
$15.70

Technical Indicators

Market Signals
Indicator
ALLO
TLRY
Relative Strength Index (RSI) 21.26 29.18
Support Level N/A N/A
Resistance Level $2.25 $3.00
Average True Range (ATR) 0.10 0.15
MACD -0.02 0.00
Stochastic Oscillator 0.42 8.57

Price Performance

Historical Comparison
ALLO
TLRY

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

About TLRY Tilray Brands Inc.

Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

Share on Social Networks: